U.S. flag

An official website of the United States government

NM_005535.3(IL12RB1):c.1058G>A (p.Gly353Glu) AND Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 18, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002051449.2

Allele description

NM_005535.3(IL12RB1):c.1058G>A (p.Gly353Glu)

Gene:
IL12RB1:interleukin 12 receptor subunit beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.11
Genomic location:
Preferred name:
NM_005535.3(IL12RB1):c.1058G>A (p.Gly353Glu)
HGVS:
  • NC_000019.10:g.18069677C>T
  • NG_007366.2:g.34273G>A
  • NM_001290023.2:c.1058G>A
  • NM_001290024.1:c.1178G>A
  • NM_005535.3:c.1058G>AMANE SELECT
  • NP_001276952.1:p.Gly353Glu
  • NP_001276953.1:p.Gly393Glu
  • NP_005526.1:p.Gly353Glu
  • LRG_72:g.34273G>A
  • NC_000019.9:g.18180487C>T
Protein change:
G353E
Links:
dbSNP: rs111768826
NCBI 1000 Genomes Browser:
rs111768826
Molecular consequence:
  • NM_001290023.2:c.1058G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001290024.1:c.1178G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005535.3:c.1058G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
Synonyms:
IL12RB1 DEFICIENCY; Immunodeficiency 30
Identifiers:
MONDO: MONDO:0013955; MedGen: C4013949; Orphanet: 319552; OMIM: 614891

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002109553Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 18, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV002109553.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 353 of the IL12RB1 protein (p.Gly353Glu). This variant is present in population databases (rs111768826, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with IL12RB1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023